Cochrane Abstracts
5‐alpha‐reductase inhibitors for prostate cancer prevention
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"5‐alpha‐reductase Inhibitors for Prostate Cancer Prevention." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5‐alpha‐reductase_inhibitors_for_prostate_cancer_prevention.
5‐alpha‐reductase inhibitors for prostate cancer prevention. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5‐alpha‐reductase_inhibitors_for_prostate_cancer_prevention. Accessed December 3, 2024.
5‐alpha‐reductase inhibitors for prostate cancer prevention. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5‐alpha‐reductase_inhibitors_for_prostate_cancer_prevention
5‐alpha‐reductase Inhibitors for Prostate Cancer Prevention [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5‐alpha‐reductase_inhibitors_for_prostate_cancer_prevention.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - 5‐alpha‐reductase inhibitors for prostate cancer prevention
ID - 437821
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437821/all/5‐alpha‐reductase_inhibitors_for_prostate_cancer_prevention
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
